Comedian Richard Lewis Passes at 76: Health Battles, Parkinson’s D…
A tribute to Richard Lewis, exploring his comedic legacy and brave health struggles, including his fight with Parkinson’s disease.
March 1, 2024
Parkinson's Blog
Tandem Cycling Study: Boosting Health in Parkinson’s Patients & Ca…
Discover how tandem cycling can improve quality of life for Parkinson’s patients and their care partners, as revealed by groundbreaking research.
March 1, 2024
A Class Above
Teaching exercise to people with Parkinson’s disease has enriched the author’s life both professionally and personally.
March 1, 2024
Scientists from IIT Mandi, US universities investigate protein involved in Parkinson’s progression
New Delhi, Feb 29 (PTI) Researchers from the Indian Institute of Technology (IIT) Mandi and three US universities have investigated a crucial protein involved in the progression of Parkinson’s disease. According to officials, Parkinson’s disease is on the rise globally, with experts projecting a substantial 200-300 per cent increase in cases in India over the […]
February 29, 2024
IIT Mandi Researcher’s Findings on Parkinson’s Protein Phosphorylation Open New Avenues for Treatment
In a groundbreaking study, the Indian Institute of Technology Mandi has collaborated with international researchers to uncover critical insights into the treatment of Parkinson’s disease. The focus of the research was on Alpha-synuclein, a brain-abundant protein that undergoes increased phosphorylation in Parkinson’s patients. Parkinson’s disease, a neurodegenerative disorder, has seen a rising prevalence globally, with […]
February 29, 2024
Amneal signs agreement with Zambon for Parkinson’s therapy
Amneal has signed an agreement with Zambon Biotech for IPX203 for the treatment of Parkinson’s disease (PD) in certain regions.
February 28, 2024
Revolutionizing Parkinson’s Treatment: North-East Trial Harnesses …
Discover how a community-led VR trial in the North-East is transforming the treatment landscape for Parkinson’s patients. Explore the innovative approach and promising outcomes of this groundbreak…
February 28, 2024
IRLAB soon to dose first patient in Phase IIb Parkinson’s disease trial
As well as a Phase IIb trial of pirepemat, IRLAB is also looking to launch a Phase III trial of its candidate mesdopetam.
February 27, 2024
Deciphering the Mysteries of Aging and Parkinson’s: A New Study Un…
Discover the latest research findings on the intricate relationship between aging, Parkinson’s disease, and dopaminergic neurons. Uncover key markers distinguishing healthy and aged cells, sheddin…
February 27, 2024
The Role of Dopamine and Serotonin in Human Social Behavior: Insig…
Recent research on Parkinson’s disease patients has uncovered a new neurochemical mechanism underlying human decision-making processes based on social context. The study sheds light on the role of…
February 26, 2024